Richard, Frank: Chromosomale Imbalancen invasiv duktaler und invasiv lobulärer Mammakarzinome detektiert mittels komparativer genomischer Hybridisierung (CGH)

45

Literatur

Albeda SM. : "Role of integrins and other cell adhesion molecules in tumor progression and metastasis (review)." Lab invest 1993 ; 68 : 4-17

Aldaz CM., Chen T., Sahin A., Cunningham J., Bondy M. : "Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas" . Cancer Res . 1995 ; 55(18) : 3976-3981

Allione F., Eisinger F., Parc P., Noguchi T., Sobol H., Birnbaum D. : "Loss of heterozygosity at loci from chromosome arm 22q in human sporadic breast carcinomas." Int. J. Cancer 1998 ; 75 : 181-186

Altucci L., Addeo R., Cicatiello L., Dauvois S., Parker MG., Truss M., Beato M., Sica V., Bresciani F., Weisz A. : "17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells." Oncogene 1996 ; 12 : 2315-2324

Anbazhagan R., Fujii H., Gabrielson E. : "Allelic loss of chromosomal arm 8p in breast cancer progression." Am. J. Pathol. 1998 ; 152(3) : 915-819

Anzick SL., Kononen J., Walker RL., Azorsa DO., Tanner MM., Guan XY., Sauter G., Kallioniemi OP., Trent JM., Meltzer PS. : "AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer." Science 1997 ; 277 : 965-968

Baffa R., Negrini M., Mandes B., Rugge M., Danzani G., Hirohashi S., Croce CM. : "Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach." Cancer Res. 1996 ; 56 : 268-273

Bender HG., Schnürch HG. : "Diagnostik und Therapie von malignen Tumoren und deren Vorstadien an der Mamma" . Bender HG., Schnürch HG (Hrsg.). Gynäkologische Onkologie , Stuttgart : Thieme 1991 , 347-354

Bentz M., Huck K., du Manoir S., Joos S., Werner CA., Fischer K., Döhner H., Lichter P. : "Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses." Blood. 1995 ; 85(12) : 3610-3618

Bentz M., Plesch A., Stilgenbauer S., Dohner H., Lichter P. : "Minimal sizes of deletions detected by comparative genomic hybridization." Genes Chromosomes Cancer 1998a ; 21(2) : 172-175

Bentz JS., Yassa N., Clayton F. : "Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases." Mod. Pathol. 1998b ; 11(9) : 814-822

Berx G., Cleton-Jansen AM., Nollet F., de Leeuw WJ., van de Vijver M., Cornelisse C., van Roy F. : "E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancer." EMBO J 1995 ; 14 : 6107-6115

Bethwaite PB., Koreth J., Herrington CS., Mc Gee JO. : "Loss of heterozygosity occurs at the D11S29 locus on Chromosome 11q23 in invasive cervical carcinoma." Br. J. Cancer 1995; 71 : 814-818

Bieche I., Liederau R. : "Genetic alterations in breast cancer." Genes Chromosomes Cancer 1995 ; 14 :227-251

Bland KI., Konstadoulakis MM., Vezeridis MP., Wanebo HJ. : "Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p 53 as prognostic discriminants for breast carcinoma." Ann Surg. 1995 ; 221(6) : 706-720

Böcker W., Kunze KD. : "Mamma: Bösartige Tumoren" , In: Böcker W.,Denk H., Heitz PhU. (Hrsg.), Pathologie, München Wien Baltimore, Urban & Schwarzenberg, 1997, S. 857-866

Bockmühl U., Petersen S., Schmidt S., Wolf G., Jahnke V., Dietel M., Petersen I. : "Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas." Cancer Res. 1997 ; 57(23) : 5213-5216


46

Bockmühl U., Wolf G., Schmidt S., Schwendel A., Jahnke V., Dietel M., Petersen I. : "Genomic alterations associated with malignancy in head and neck cancer." Head Neck 1998 ; 20(2) : 145-151

Borg A., Zhang QX., Alm P., Olsson H., Sellberg G. : "The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene expression." Cancer Res. 1992 ; 52 : 2991-2994

Brewster SF., Gingell JC., Browne S., Brown KW.: "Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder." Br. J. Cancer 1994 ; 70(4) : 697-700

Brison O. : "Gene amplification and tumour progression." Biochym Biophys Acta 1993 ; 1155 : 25-41

Bukholm IK., Nesland JM., Karesen R., Jacobsen U., Borresen-Dale AL. : "Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas." Virchows Arch. 1997 ; 431 : 317-321

Carlson KM., Bruder C., Nordenskjold M., Dumanski JP. : "1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization." Genes Chromosomes Cancer 1997 ; 20(4) : 419-424

Carter SL., Negrini M., Baffa R., Gillum DR., Rosenber AL., Schwartz GF., Croce CM. : "Loss of heterozygosity at 11q23-23 in breast cancer." Cancer Res. 1994 ; 54 : 6270-6274

Casolo P., Raspadori A., Drei B., Amuso D., Mosca D., Amorotti C., Di Blasio P., De Maria R., De Luca G., Colli G., Ganz E. : "Natural history of breast cancer: lobular carcinoma versus ductal carcinoma in our experience." Ann. Ital. Chir. 1997 ; 68(1) : 43-47

Chang-Claude J., Becher H., Hamann U., Schroeder-Kurth T. : "Risikoabschätzung für das familiäre Auftreten von Brustkrebs." Zentralbl Gynäkol 1995 ; 117 : 423-434

Chappell SA., Walsh T., Walker RA., Shaw JA. : "Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas." Br. J. Cancer 1997 ; 75(9) : 1324-1329

Chen LC., Matsumura K., Deng G., Kurisu W., Ljung BM., Lerman MI., Waldman FM., Smith HS. :"Deletion of two separate regions on chromosome 3p in breast cancers." Cancer Res. 1994 ; 54 : 3021-3024

Cher ML., MacGrogan D., Bookstein R., Brown JA., Jenkins RB., Jensen RH. : "Comparative genomic hybridization allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer." Genes Chromosomes Cancer 1994 ; 11(3) : 153-162

Clark GM., McGuire WL. : "Follow-up study of HER-2/neu amplification in primary breast cancer." Cancer Res. 1991 ; 51(3) : 944-948

Cleton-Jansen AM., Moerland EW., Kuipers-Dighshoorn NJ., Callen DF., Sutherland GR., Hansen B., Devilee P., Cornelisse CJ. : "At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer." Genes Chromosomes Cancer 1994 ; 9 :101-107

Coagner FB. : "History of breast disease and its treatment." In: Bland KI., Copeland EM.: The breast ; Philadelphia USA , Saunders, 1991 : 166

Clifford SC., Prowse AH., Affara NA., Buys CH., Maher ER. : "Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis." Genes Chromosomes Cancer 1998 ; 22(3) : 200-209

Courjal F., Louason G., Speiser P., Katsaros D., Zeillinger R., Theillet C. : "Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors." Int. J. Cancer 1996 ; 69(4) : 247-253

Courjal F., Theillet C. . "Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification." Cancer Res. 1997 ; 57(19) : 4368-4377


47

Cremer T., Jauch A., Ried T., Schröck E., Lengauer C., Cremer M., Speicher MR. : "Fluoreszenz-in-situ-Hybridisierung (FISH)." Dt. Ärztebl. 1995 ; 92 : A-1593-1601 [Heft 22]

Cropp CS., Liedereau R., Campbell G., Champene MH., Callahan R. : "Loss of heterozygosity on chromosome 17 and 18 in breast carcinoma: Two additional regions identified." Proc. Natl. Acad. Sci. 1990 ; 87 : 7737-7741

De Corte V., De Potter C., Vandenberghe D., Van Laerebeke, Azam M., Roels H., Mareel M., Vanderkerckhove J. : "A 50-kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility and activates tyrosin phosphorylation of Neu/Her-2 in human SK-BR-3 mammary cancer cells." J. Cell. Sci. 1994 ; 107 : 405-416

Deng G., Chen LC., Schott DR., Thor A., Bhargava V., Ljung BM., Chew K., Smith HS. : "Loss of heterozygosity and p 53 mutations in breast cancer." Cancer Res. 1994 ; 54(2) : 499-505

Deppert W., Buschhausen-Denker G., Patschinsky T., Steinmeyer K. : "Celle cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II. Requirement for cell cycle progression." Oncogene 1990 ; 5 : 1701-1706

Devilee P., Van Villet M., Van Sloun P., Kuipers Dijkshoorn M., Hermans J., Pearson PL., Cornelisse LJ. : "Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q." Oncogene 1991 ; 6 : 1705-1711

Devilee P., Schuuring E., van de Vijer MJ., Cornelisse CJ. : "Recent developments in the molecular genetic understanding of breast cancer." Crit Rev Oncol 1994 ; 5 : 247-270

Di Fiore PP., Pierce JH., Kraus MH., Segatto O., King CR., Aaronson SA. : "ErbB-2 is a potent oncogene when overexpressed in NIH/3TH cells." Science 1987 ; 237 : 178-182

Dorion-Bonnet F., Mautalen S., Hostein I., Longy M. : "Allelic imbalance study of 16q in human primary breast carcinoma using microsatellite markers." Genes Chromosomes Cancer 1995 ; 14(3) : 171-181

Dublin EA., Neera KP., Gillett CE., Smith P., Peters G., Barnes DM. : "Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters." Int. J. Cancer 1998 ; 79 : 71-75

Du Manoir S., Speicher MR., Joos S., Schröck E., Popp S., Döhner H., Kovacs G., Robert-Nicaud M., Lichter P., Cremer T. : "Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization." Hum. Genet. 1993 ; 90 : 590-610

Dutrillaux B., Gerbault-Seureau M., Zafrani B. : "Characterization of chromosomal abnormalities in human breast cancer." Cancer Genet. Cytogenet. 1990 ; 49 : 203-217

Eagle LR., Yin X., Brothman AR., Williams BJ., Atkin NB., Prochownik EV. : "Mutation of the MXII gene in prostate cancer." Nature Genet 1995 ; 9 : 249-255

Early Breast Cancer Trialist’ Collaborative Group : "Tamoxifen for early breast cancer: an overview of the randomised trials." THE LANCET 1998 ; 351 : 1451-1467

Farabegoli F., Ceccarelli C., Santini D., Trere´ D., Baldini N., Taffurelli M., Derenzini M. : "Chromosome 1 aneusomy with 1p36 under-representation is related to histologic grade, DNA aneuploidy, high c-erbB-2 and loss of bcl-2 expression in ductal breast carcinoma." Int. J. Cancer. 1996 ; 69 : 381-385

Fearon ER., Vogelstein B. : "A genetic model for colorectal tumorigenesis." Cell 1990 ; 61 : 759-767

Fields S., Jang SK. : "Presence of a potent transcription activating sequence in the p53 protein." Science 1990 ; 249 : 1046-1049

Fukushige SI., Matsubara KI., Yoshida M., Sasaki M., Suzuki T., Semba K., Toyshima K., Yamamoto T. : "Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line." Mol. Cell. Biol. 1986 ; 6 : 955-959


48

Garcia-Foncillas J., Zornoza G., Martinez MJ., Gonzalez MJ., Hidalgo OF., Brugarolas A., Moreno-Palanques RF. : "Genetic instability, oncogene expression and/or DNA methylation is associated with inactivation of estrogen receptor (ER) in breast cancer (Meeting abstract)." Proc. Annu. Meet. Am. Assoc. Cancer Res. 1996 ; 37 : A3965

Gaudray P., Szepetowski P., Escot C., Birnbaum D., Theillet C. : "DNA amplification at 11q13 in human cancer: From complexity to perplexity." Mutat. Res. 1992 ; 3 : 317-328

Geradts J., Kratzke RA., Niehans GA., Lincoln CE. : "Immunohistochemical detection of the cyclin-dependent kinase-inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INKFA in archival human solid tumors: correlation with retinoblastoma protein expression." Cancer Res. 1995 ; 55 : 6006-6011

Gillett C., Fantl V., Smith R., Fisher C., Bartek J., Dickson C., Barnes D., Peters G .: "Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining." Cancer Res. 1994 ; 54 : 1812-1817

Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M. : "Identification and characterization of the familial adenomatous polyposis coli gene." Cell 1991 ; 66(3) : 589-600

Gusterson BA., Machin LG., Gullick WJ., Gibbs NM., Powles TJ., Elliott C., Ashley S., Monaghan P., Harrison S. : "c-erbB-2 expression in benign and malignant breast disease." Br. J. Cancer 1988 ; 58 : 453-457

Habuchi T., Luscombe M., Elder PA., Knowles MA. : "Structure and methylation-based silencing of a gene (DBCCR1) within a canditate bladder cancer tumor suppressor region at 9q32-q33." Genomics 1998 ; 48(3) : 277-288

Hall M., Peters G. : "Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer." Adv. Cancer Res. 1996 ; 68 : 67-108

Hamann U., Herbold C., Costa S., Solomayer EF., Kaufmann M., Bastert G., Ulmer HU., Frenzel H., Komitowski D. : "Allelic imbalance on chromosome 13q: Evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer." Cancer Res. 1996 ; 56 : 1988-1990

Hampton GM., Mannermaa A., Winquist R., Alavaikko M., Blanco G., Taskinen PJ., Kiviniemi H., Newsham I., Cavenee WK., Evans GA. : "Loss of heterozygosity in human sporadic breast carcinoma: a common region between 11q22 and 11q23.3." Cancer Res. 1994 ; 54(17) : 4586-4589

Harada T., Irving RM., Xuereb JH., Barton DE., Hardy DG., Moffat DA., Maher ER. : "Molecular genetic investigation of the neurofibromatosis-type-2 tumor-suppressor gene in sporadic meningioma." J. Neurosurg. 1996 ; 84 : 847-851

Herbst RA., Larson A., Weiss J., Cavenee WK., Hampton GM., Arden KC. : "A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma." Cancer Res. 1995 ; 55 : 2494-2496

Hui R., Ball JR., Macmillan RD., Kenny FS., Prall OWJ., Campbell DH., Cornish AL., McClelland A., Daly RJ., Forbes JF., Blamey RW., Musgrove EA., Robertson JFR., Nicholson RI., Sutherland RL. : "EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival." Oncogene 1998 ; 17 : 1053-1059

Imbert A., Chaffanet M., Essioux L., Noguchi T., Adelaide J., Kerangueven F., Le Paslier D., Bonaiti-Pellie C., Sobol H., Birnbaum D., Pebusque MJ. : "Integrated map of the chromosome 8p12-p21 region, a region involved in human cancers and Werner Syndrome." Genomics 1996 ; 32 ; 29-38

Isola J., Visakorpi T., Holli K., Kallioniemi OP. : "Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients." J. Natl. Cancer Inst. 1992 ; 84(14) : 1109-1114


49

Isola J., DeVries S., Chu L., Ghazvini S., Waldman F. : "Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples." Am. J. Pathol. 1994 ; 145(6) : 1301-1308

Isola JJ., Kallioniemi OP., Chu LW., Fuqua SA., Hilsenbeck SG., Osborne CK., Waldman FM. : "Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer." Am. J. Pathol. 1995 ; 147(4) : 905-911

Isshiki K., Elder DE., Guerry D., Linnenbach AJ. : "Chromosome 10 allelic loss in malignant melanoma." Genes Chromosomes Cancer 1993 ; 8 : 178-184

James LA., Mitchell EL., Menasce L., Varley JM. : "Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma." Oncogene 1997 ; 14(9) : 1059-1065

Jeng MH., Shupnik MA., Bender TP., Westin EH., Bandyopadhyay D., Kumar R., Masamura S., Santen RJ. : "Estrogen receptor expression and function in long-term Estrogen-deprived human breast cancer cells." Endocrinology 1998 ; 139 : 4164-4174

Jones N. : "Structure and function of transcription factors." Semin. Cancer Biol. 1990 ; 1 : 5-17

Kallioniemi A., Kallioniemi OP., Sudar D., Rutovitz D., Gray JW., Waldman F., Pinkel D. : "Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors." Science 1992 ; 258 : 818-821

Kallioniemi A., Kallioniemi OP., Piper J., Tanner M., Stokke T., Chen L., Smith HS., Pinkel D., Gray JW., Waldman FM. : "Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization." Proc. Natl. Acad. Sci. 1994a ; 91 : 2156-2160

Kallioniemi OP., Kallioniemi A., Piper J., Isola J., Waldman FM., Gray JW., Pinkel D. : "Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors." Genes Chromosomes Cancer 1994b ; 10 : 231-243

Kelsey JL., Berkowitz GS. : "Breast cancer epidemiology." Cancer Res. 1988 ; 48 : 5615-5623

Kelsey JL., Gammon MD. : "Epidemiology of breast cancer." Epidemiol. Rev. 1990 ; 12 : 228-240

Kerangueven F., Essioux L., Dib A., Noguchi T., Allione F., Geneix J., Longy M., Lidereau R., Eisinger F., Pebusque MJ., Jacquemir J., Bonaiti-Pellie C., Sobol H., Birnbaum D. : "Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8" . Oncogene 1995 ; 10 : 1023-1026

Kinzler KW., Nilbert MC., Su LK., Vogelstein B., Bryan TM., Levy DB., Smith KJ., Preisinger AC., Hedge P., McKechnie D., Finniear R., Markham A., Groffen J., Boguski MS., Aschul FS., Horii A., Ando H., Miyoshi Y., Miki Y., Nishisho I., Nakamura Y. : "Identification of FAP locus genes from chromosome 5q21." Science 1991 ; 253 : 661-665

Knowles MA., Shaw ME., Proctor AJ. : "Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment lenght polymorphisms and microsatellite polymorphisms." Oncogene 1993 ; 8 : 1357-1364

Koreth J., Bakkenist CJ., Mc Gee JO. : "Allelic deletions at chromosome 11q22-23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers." Oncogene 1997 ; 14 : 431-437

Kratzke RA., Greatens TM., Rubins JB., Maddaus MA., Niewoehner DE., Niehans GA., Geradts J. : "RB and p16INK4 expression in resected non-small cell lung tumors." Cancer Res. 1996 ; 56 : 3415-3420

Kreipe H., Feist H., Fischer L., Felgner J., Heidorn K., Mettler L., Parwaresch R. : "Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer." Cancer Res. 1993 ; 53 : 1956-1961


50

Kuuskasjarvi T., Tanner M., Pennanen S., Karhu R., Kallioniemi OP., Isola J. : "Genetic changes in intraductal breast cancer detected by comparative genomic hybridization." Am. J. Pathol. 1997 ; 150(4) : 1465-1471

Lammie GA., Peters G. : "Chromosome 11q13 abnormalities in human cancer." Cancer Cells 1991 ; 3 : 413-420

Lammie GA., Fantl V., Smith R., Schuuring E., Brookes S., Michalides R., Dickson C., Arnold A., Peters G. : "D11s287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1." Oncogene 1991 ; 6 : 439-444

Larsson C., Bryström C., Skoog L., Rotstein S., Nordenskjöld M. : "Genomic alterations in human breast carcinomas." Genes Chromosomes Cancer 1990 ; 2 : 191-197

Leder A., Pattengale PK., Kuo A., Stewart TA., Leder P. : "Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development." Cell 1986 ; 45 : 485-495

Mahlamaki EH., Hoglund M., Gorunova L., Karhu R., Dawiskiba S., Andren-Sandberg A., Kallioniemi OP., Johansson B. : "Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer." Genes Chromosomes Cancer 1997 ; 20(4) : 383-391

Marchetti A., Buttita F., Pellegrini S., Campani D., Diella F., Cecchetti D., Callahan R., Bistocchi M. : "p53 mutations and histological type of invasive breast carcinoma." Cancer Res. 1993 ; 53 : 4665-4669

Martinazzi M., Crivelli F., Zampatti C., Martinazzi S. : "Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma." J. Clin. Pathol. 1993 ; 46 : 1009-1010

Meichle A., Philipp A., Eilers M. : "The function of myc proteins." Biochym Biophysi Acta 1992 ; 1114 : 129-146

Moll R., Mitze M., Frixen UH., Birchmeier W. : "Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas." Amer. J. Pathol. 1993 ; 143 : 1731-1742

Murphy DS., McHardy P., Coutts J., Mallon EA., George WD., Kaye SB., Brown R., Keith WN. : "Interphase cytogenetic analysis of erbB-2 and topo I-alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ." Int. J. Cancer 1995 ; 64 : 18-26

Nishizaki T., Isola J., Kallioniemi O., Kallioniemi A., Weidner N., Chew K., Waldman FM. : "Genetic changes in lobular breast cancers detected by comparative genomic hybridization (Meeting abstract)." Proc. Annu. Meet. Am. Assoc. Cancer Res. 1995 ; 36 : A3286

Nishizaki T., DeVries S., Chew K., Goodson III WH., Ljung BM., Thor A., Waldman FM. : "Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization." Genes Chromosomes Cancer 1997a ; 19(4) : 267-272

Nishizaki T., Chew K., Chu L., Isola J., Kallioniemi A., Weidner N., Waldman FM. : "Genetic alterations in lobular breast cancer by comparative genomic hybridization." Int. J. Cancer 1997b ; 74(5) : 513-517

Nishizuka S., Tamura S., Terashima M., Satodate R. : "Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach." J. Pathol. 1998 ; 185(1) : 38-43

Nupponen NN., Hyytinen ER., Kallioniemi AH., Visakorpi T. : "Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization." Cancer Genet. Cytogenet. 1998 ; 101(1) : 53-57

Ohgaki K., Iida A., Kasumi F., Sakamoto G., Akimoto M., Nakamura Y., Emi M. : "Mapping of a new target region of allelic loss to a 6-cM interval at 21q21 in primary breast cancers. " Genes Chromosomes Cancer 1998 ; 23(3) : 244-247


51

Ottaviano YG., Issa JP., Parl FF. : "Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells." Cancer Res. 1994 ; 54 : 2552-2555

Page DL., Dupont WD. : "Anatomic markers of human premalignancy and risk of breast cancer." Cancer 1990 ; 66 : 1326-1335

Paik S., Bryant J., Park C., Fisher B., Tan-Chiu E., Hyams D., Fisher ER., Lippmann ME., Wickerham DL., Wolmark N. : "erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer." J. Natl. Cancer Inst. 1998 ; 90(18) : 1361-1370

Palacios J., Benito N., Pizarro A., Suarez A., Espada J., Cano A., Gamallo C. : "Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features." Am. J. Pathol. 1995 ; 146 : 605-612

Pandis N., Jin Y., Limon J., Bardi G., Idvall I., Mandahl N., Mitelman F., Heim S. : "Interstitial deletion of the short arm of chromosome 3 as a primary chromosome abnormality in carcinomas of the breast." Genes Chromosomes Cancer 1993 ; 6 : 151-155

Pandis N., Bardi G., Mitelman F., Heim S. : "Deletion of the short arm of chromosome 3 in breast carcinomas." Genes Chromosomes Cancer 1997 ; 18 : 241-245

Papi L., De Vitis LR., Vitelli F., Ammannati F., Mennonna P., Montali E., Bigozzi U. : "Somatic mutations in the neurofibromatosis-type-2 gene in sporadic meningiomas." Hum. Genet . 1995 ; 95 : 347-351

Petersen I., Schwendel A., Bockmühl U., Dietel M. : "Die komparative genomische Hybridisierung: Eine Screeningmethode in der genetischen Tumordiagnostik." Pathologe 1996 ; 17 : 333-341

Petersen I., Langreck H., Wolf G., Schwendel A., Psille R., Vogt P., Reichel MB., Ried T., Dietel M. : "Small cell lung cancer is characterized by a high incidence of deletions on chromosome 3p, 4q, 5q, 10q, 13q and 17p." Br. J. Cancer 1997 ; 75 : 79-86

Polito P., Cin PD., Pauwels P., Christiaens M., Van den Berghe I., Moerman P., Vrints L., Van den Berghe H. : "An important subgroup of phyllodes tumors of the breast is characterized by rearrangements of chromosome 1q and 10q." Oncol. Rep. 1998 ; 5(5) : 1099-1102

Prall OWJ., Sarcevic B., Musgrove EA., Watts CKW., Sutherland RL. : "Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2." J. Biol. Chem. 1997 ; 272 : 10882-10894

Prendergast GC., Lawe D., Ziff EB. : "Association of myn, the murine homologue of max with c-myc stimulating methylation-sensitive DNA binding and ras cotransformation." Cell 1991 ; 65 : 395-407

Raycroft L., Wu H., Lozano G. : "Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene." Science 1990 ; 249 : 1049-1051

Rempel SA., Schwechheimer K., Davis RL., Cavanee WK., Rosenblum ML. : "Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningeoma progression." Cancer Res. 1993 ; 53 : 2386-2392

Resnitzky D., Gossen M., Bujard H., Reed SI. : "Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol." Cell. Biol. 1994 ; 14 : 1669-1679

Rhei E., Kang L., Bogomolniy F., Federici MG., Borgen PI., Boyd J. : "Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas." Cancer Res. 1997 ; 57(17) : 3657-3659

Ried T., Petersen I., Holtgreve-Grez H., Speicher MR., Schröck E., du Manoir S., Cremer T. : "Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization." Cancer Res. 1994 ; 54 : 1801-1806


52

Ried T., Just KE., Holtgreve-Grez H., du Manoir S., Speicher MR., Schröck E., Latham C., Blegen H., Zetterberg A., Cremer T., Auer G. : "Comparative genomic Hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas." Cancer Res. 1995 ; 55 : 5415-5423

Roth K., Wolf G., Dietel M., Petersen I. : "Analyseprogramm zur quantitativen Erfassung chromosomaler Aberrationen mittels komparativer genomischer Hybridisierung (CGH)." Pathologe 1996 ; 17 : 342-348

Rusty AK., Dyson N., Bernards R. : "Amino terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product." Nature 1991 ; 352 : 541-544

Sato T., Tanigami A., Yamakawa K., Akiyama F., Kasumi F., Sakamoto G., Nakamura Y. : "Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer." Cancer Res. 1990 ; 50 : 7814-7819

Sato T., Akiyama F., Sakamoto G., Kasumi F. und Nakamura Y. : "Accumulation of genetic alterations and progression of primary breast cancer." Cancer Res. 1991 ; 51 :5794-5799

Sauter G. : "Rudolf Virchow Prize 1997. Molecular cytogenetic analysis of superficial urothelial cancer of the bladder." Verh. Dtsch. Ges. Pathol. 1997 ; 81 : 18-27

Schneider NR., Williams WR., Chaganti RSK. : "Genetic epidemiology of familial aggregation of cancer." Adv. Cancer Res. 1986 ; 47 : 1-36

Schreiber-Agus N., Meng Y., Hoang T., Hou H. Jr, Chen K., Greenberg R., Cordon-Cardo C., Lee HW., DePinho RA. : "Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth." Nature 1998 ; 3939(6684) : 483-487

Schwendel A., Richard F., Langreck H., Kaufmann O., Lage H., Winzer KJ., Petersen I., Dietel M. : "Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q." Br. J. Cancer 1998a ; 78(6) : 806-811

Schwendel A., Richard F., Pacyna-Gengelbach M., Petersen I., Winzer KJ., Dietel M. : "DNA copy number changes in lobular breast carcinomas." 17th International Cancer Congress, Rio de Janeiro, Brazil, 24.- 28. August 1998b ; Congress Paper: 753-757

Seitz S., Rohde K., Bender E., Nothnagel A., Pidde H., Ullrich OM., El-Zehairy A., Haensch W., Jandrig B., Kölble K., Schlag PM., Scherneck S. : "Deletion mapping and linkage analysis provide strong indication for the involvement of thr human chromosome region 8p12-p22 in breast carcinogenesis." Br. J. Cancer 1997 ; 76(8) : 983-991

Sekido Y., Bader S., Latif F., Gnarra JR., Gazdar AF., Linehan WM., Zbar B., Lerman MI., Minna JD. : "Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines." Oncogene 1994 ; 9(6) : 1599-1604

Sekido Y., Ahmadian M., Wistuba II., Latif F., Bader S., Ming-Hui W., Wei MH., Duh FM., Gazdar AF., Lerman MI., Minna JD. : "Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene." Oncogene 1998 ; 16 : 3151-3157

Serrano M., Hannon G., Beach D. : "A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4." Nature 1993 ; 366 : 704-707

Shaulsky G., Goldfinger N., Peled A., Rotter V. : "Involvement of wild-type p53 in pre-B-cell differentiation in vitro." Proc. Natl. Acad. Sci. 1991 ; 88 : 8982-8986

Shaw P., Bavey R., Tardy S., Sahli R., Sordat B., Costa J. : "Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line." Proc. Natl. Acad. Sci. 1992 ; 89 : 4495-4499

Shaw ME, Knowles MA. : "Deletion mapping of chromosome 11 in carcinoma of the bladder." Genes Chromosomes Cancer 1995 ; 13 : 1-8

Sherr CJ. : "Mammalian G1 cyclins" . Cell 1993 ; 73 : 1059-106


53

Silverstein MJ., Lewinsky BS., Waisman JR., Gierson ED., Colburn WJ., Senofsky GM., Gamagami P. : "Infiltrating lobular carcinoma. Is it different from Infiltrating duct carcinoma?" Cancer 1994 ; 73 : 1673-1677

Sinn HP., Kellerhoff NM., Kellerhoff R., Bastert G., Otto HF. : "Subtypisierung und Prognoseabschätzung beim invasiven lobulären Mammakarziom." Pathologe 1997 ; 18 : 37-44

Skirnisdottir S., Eiriksdottir G., Baldursson T., Barkardottir RB., Egilsson V., Ingvarsson S. : "High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: correlation with high PgR and low s-phase." Int. J. Cancer 1995 ; 64 : 112-116

Slamon DJ., Clark GM., Wong SG., Levin WJ., Ullrich A., McGuire WL. : "Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene." Science 1987 ; 235 : 177-181

Sonoda G., Palazzo J, du Manoir S, Godwin AK, Feder M, Yakushiji M, Testa JR. : "Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas." Genes Chromosomes Cancer 1997 ; 20(4) : 320-328

Sozzi G., Veronese ML., Negrini M., Baffa R., Coticelli MG., Inoue H., Tornielli S., Pilotti S., De Gregorio L., Pastorino U., Pierotti MA., Ohta M., Huebner K., Croce CM.: "The FHIT gene at 3p14.2 is abnormal in lung cancer. " Cell 1996 ; 85 : 1-20

Staibano S., Migogna MD., Lo Muzio L., Di Alberti L., Di Natale E., Lucariello A., Mezza E., Bucci E., DeRosa G. : "Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity. " Hum. Pathol. 1998 ; 29(11) : 1189-1194

Steck PA., Pershouse MA., Jasser Sa., Yung WK., Lin H., Ligon AH., Langford LA., Baumgard ML., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng DH., Tavtigian SV. : "Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers." Nat. Genet. 1997 ; 15(4) : 356-362

Steinmeyer K., Maacke H., Deppert W. : "Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. I. Regulation of p53 expression" . Oncogene 1990 ; 5 : 1691-1700

Suzuki H., Emi M., Komiya A., Fujiwara Y., Yatani R., Nakamura Y., Shimazaki J. : "Localization of a tumour suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3." Genes Chromosomes Cancer 1995 ; 13 : 168-174

Swift M., Morrell D., Massey RB., Chase CL. : "Incidence of cancer in 161 families affected by ataxia-teleangiectasia." N.Engl. J. Med. 1991 ; 325 : 1831-1836

Takeichi M. : "Cadherin cell adhesion receptors as a morphogenetic regulator." Science. 1991 ; 251 : 1451-1455

Tanaka K., Kikuchi-Yanoshita R., Muraoka M., Konishi M., Oshimura M., Miyaki M. : "Suppression of tumorigenicity and invasiveness of colon carcinoma cells by introduction of normal chromosome 8p12-pter." Oncogene 1996 ; 12 : 405-410

Tanner MM., Karhu RA., Nupponen NN., Borg A., Baldetorp B:; Pejovic T., Ferno M., Killander D., Isola JJ. : "Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene." Am. J. Pathol. 1998 ; 153(1) : 191-199

Tavassoli FA. : "Infiltrating lobular carcinoma." In: Tavassoli FA. (Hrsg.), Pathology of the breast. Norwalk : Appleton and Lange 1992 ; 307-315

Teng DH., Hu R., Lin H., Davis T., Iliev D., Frye C., Swedlund B., Hansen KL., Vinson VL., Gumpper KL., Ellis L., El-Naggar A., Frazier M., Jasser S., Langford LA., Lee J., Mills GB., Pershouse MA., Pollack RE., Tornos C., Troncoso P., Yung WK., Fujii G., Berson A., Steck PA. et al. : "MMAC1/PTEN mutations in primary specimens and tumor cell lines." Cancer Res. 1997 ; 57(23) : 5221-5225


54

Terada T., Ashida K., Endo K., Horie S., Maeta H., Matsunaga Y., Takashima K., Ohta T., Kitamura Y. : "c-erbB-2 protein is expressed in hepatholithiasis and cholangiocarcinoma." Histopathology 1998 ; 33(4) : 325-331

Thompson AM., Anderson TJ., Condie A., Prosser J., Chetty U., Carter DC., Evans HJ., Steel CM. : "p53 allele losses, mutations, and expression in breast cancer and their relationship to clinico-pathological parameters." Int. J. Cancer 1992 ; 50 : 528-532

Thompson F., Emerson J.,Dalton W., Yang JM., McGee D., Villar H., Knox S., Massey K., Weinstein R., Bhattacharyya A. : "Clonal chromosome abnormalities in human breast carcinomas. I. Twenty-eight cases with primary disease." Genes Chromosomes Cancer 1993 ; 7(4) : 185-193

Tirkkonen M., Tanner M., Karhu R., Kallioniemi A., Isola J. and Kallioniemi OP. : "Molecular cytogenetics of primary breast cancer by CGH." Genes Chromosomes Cancer 1998 ; 21 :177-184

Trent J., Yang JM., Emerson J., Dalton W., McGee D., Massey K., Thompson F., Villar H. : "Clonal chromosome abnormalities in human breast carcinomas. II. Thirty-four cases with metastatic disease." Genes Chromosomes Cancer 1993 ; 7(4) : 194-203

Tsai YC., Nichols PW., Hiti AL., Williams Z., Skinner DG., Jones PA. : "Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer." Cancer Res. 1990 ; 50(1) : 44-47

Tsuda H., Hirohashi S., Shimosato Y., Hirota T., Tsugane S., Yamamoto H., Miyajima N., Toyoshima K., Yamamoto T., Yokota J., Yoshida T., Sakamoto H., Terada M., Sugimura T. : "Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1." Cancer Res. 1989 ; 49(11) : 3104-3108

Tsuda H., Callen DF., Fukotomi T., Nakamura Y., Hirohashi S. : "Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extend of spread." Cancer Res. 1994 ; 54(2) : 513-517

Tsuda H., Sakamaki C., Tsugane S., Fukutomi T., Hirohashi S. : "Prognostic significance of accumulation of gene and chromosome alterations and histological grade in node-negative breast carcinoma." Jpn. J. Clin. Oncol. 1998 ; Jan 28(1) : 5-11

Van de Vijver MJ. : "Molecular genetic changes in human breast cancer." Adv. Cancer Res. 1993 ; 61 : 25-56

Voorter C., Joos S., Bringuir PP., Vallinga M., Poddighe P., Schalken J., du Manoir S., Ramaekers F., Lichter P., Hopman A. : "Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization." Am. J. Pathol. 1995 ; 146(6) : 1341-1354

Vos CBJ., Cleton-Jansen AM., Berx G., de Leeuw WJF., ter Haar NT., van Roy F., Cornelisse CJ., Peterse JL., van de Vijver MJ. : "E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis." Br. J. Cancer. 1997 ; 76(9) : 1131-1133

Weber RG., Bostrom J., Wolter M., Baudis M., Collins VP., Reifenberger G., Lichter P. : "Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression." Proc. Natl. Acad. Sci. 1997 ; 94(26) : 14719-14724

Weinberg RA. : "The retinoblastoma protein and cell cycle control." Cell 1995 ; 81 : 323-330

Wellings SR., Jensen HM., Marcum RG. : "An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions." J. Natl. Cancer Inst. 1975 ; 55 : 231-273

Willem P., Mendelow B. : "12p rearrangement and DNA amplification mapped by comparative genomic hybridization in a patient with secondary myeloid leukemia." Cancer Genet. Cytogenet. 1997 ; 99(1) : 30-37

Winqvist R., Hampton GM., Mannermaa A., Blanco G., Alavaikko M., Kiriniemi H., Taskinen PJ., Evans GA., Wright FA., Newsham I., Cavenee WK .: "Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis." Cancer Res. 1995 ; 55 :


55

2660-2664

Wittekind CH., Wagner G. : "Klassifikation von Mammakarzinomen" , In: Wittekind CH., Wagner G. (Hrsg.), TNM: Klassifikation maligner Tumoren. 5. Auflage, Berlin Heidelberg , Springer 1997 ;

Wooster R., Neuhausen SL., Mangion J., Quirk Y., Ford D., Collins N., Nguyen K., Seal S., Trau T., Averill D. et al. : "Localization of a breast cancer susceptibility gene, BRCA 2, to chromosome 13q12-13." Science 1994 ; 265 : 2088-2090

Wu H., Reynolds AB., Kanner SB., Vines RR., Parsons JT. : "Identification and characterization of a novel cytoskeleton-associated pp60src substrate." Mol. Cell. Biol. 1991 ; 11 : 5113-5124

Yaegashi S., Sachse R., Okuchi N., Mori S., Sekiya T. : "Low incidence of a nucleotide-sequence alteration of the neurofibromatosis-type-2 gene in human breast cancers." Jap. J. Cancer Res. 1995 ; 86 : 929-933

Yaremko ML., Kutza C., Lyzak J., Mick R., Recant WM., Westbrook CA. : "Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer." Genes Chromosomes Cancer 1996 ; 16 : 189-195

Yeatman TJ., Bland KI. : "Staging of breast cancer." In: Bland KI., Copeland EM. (Hrsg.): The breast. Philadelphia USA, Saunders 1991 : 313-330

Yeatman TJ., Cantor AB., Smith TJ., Smith SK., Reitgen DS., Miller MS., Ku NN., Baekey PA., Cox CE. : "Tumor biology of infiltrating lobular carcinoma. Implications for management." Ann. Surg. 1995 ; 222(4) : 549-559

Yin Y., Tainsky MA., Bischoff FZ., Strong LC., Wahl GM. : "Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles." Cell 1992 ; 70 : 937-948

Yokota T., Matsumoto S., Yoshimoto M., Kasumi F., Akiyama F., Sakamoto G., Nakamura Y., Emi M. : "Mapping of a breast cancer tumor suppresoor gene locus to a 4-cM interval on chromosome 18q21." Jpn. J. Cancer Res. 1997 ; Oct 88(10) : 959-964

Yu D., Hung MC. : "Expression of activated " "rat" " neu oncogene is sufficient to induce experimental metastasis in 3T3 cells." Oncogene 1991 ; 6 : 1991-1996


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.

DiML DTD Version 2.0
Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML - Version erstellt am:
Thu Sep 20 11:14:14 2001